N. Morikawa

发表

Pharmacokinetics of piperacillin-tazobactam in plasma, peritoneal fluid and peritoneum of surgery patients, and dosing considerations based on site-specific pharmacodynamic target attainment.

N. Murao, N. Shigemoto, H. Ohge, 2017, International journal of antimicrobial agents.

Determination of Granisetron in Human Plasma by High-performance Liquid Chromatography

M. Takeyama, K. Ikawa, N. Morikawa, 1997 .

Optimized dosage and frequency of cefozopran for patients with febrile neutropenia based on population pharmacokinetic and pharmacodynamic analysis.

M. Taniwaki, T. Komori, K. Ikawa, 2008, The Journal of antimicrobial chemotherapy.

Pharmacokinetic and pharmacodynamic profiling of cefepime in plasma and peritoneal fluid of abdominal surgery patients.

H. Ohge, T. Sueda, K. Ikawa, 2007, International journal of antimicrobial agents.

Population pharmacokinetics of high‐dose methotrexate in Japanese adult patients with malignancies: a concurrent analysis of the serum and urine concentration data

K. Ikawa, N. Morikawa, K. Kumagai, 2008, Journal of clinical pharmacy and therapeutics.

Pharmacokinetics of Methotrexate in Plasma and Cerebrospinal Fluid

T. Abe, M. Takeyama, N. Morikawa, 1997, The Annals of pharmacotherapy.

Pharmacokinetic modelling of serum and bronchial concentrations for clarithromycin and telithromycin, and site‐specific pharmacodynamic simulation for their dosages

H. Derendorf, K. Ikawa, N. Morikawa, 2014, Journal of clinical pharmacy and therapeutics.

Significant association between hand-foot syndrome and efficacy of capecitabine in patients with metastatic breast cancer.

Y. Fujiwara, Yoshiro Saito, M. Tohkin, 2012, Biological & pharmaceutical bulletin.

Which Has Superior Acid-Suppressive Effect, 10 Mg Omeprazole Once Daily or 20 Mg Famotidine Twice Daily? Effects of Single or Repeated Administration in Japanese Helicobacter Pylori-Negative CYP2C19 Extensive Metabolizers

J. Xu, S. Tazuma, K. Ikawa, 2007, Digestive Diseases and Sciences.

Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Simulation of Piperacillin/Tazobactam for Dosing Optimization in Late Elderly Patients with Pneumonia

T. Isobe, K. Ikawa, N. Morikawa, 2020, Antibiotics.

Dosing Optimization of Ampicillin-Sulbactam Based on Cystatin C in Elderly Patients with Pneumonia.

Kazuaki Matsumoto, H. Terazono, K. Ikawa, 2021, Biological & pharmaceutical bulletin.

Evaluation of the efficacy and safety of biapenem against pneumonia in the elderly and a study on its pharmacokinetics

Mitsuhiro Tada, T. Isobe, K. Ikawa, 2013, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Risk factors for ganciclovir-induced thrombocytopenia and leukopenia.

Kazuaki Matsumoto, K. Ikawa, N. Morikawa, 2015, Biological & pharmaceutical bulletin.

Reduction in the incidence of MRSA with use of alcohol-based hand rub solutions and gloves

Kazuaki Matsumoto, K. Ikawa, N. Morikawa, 2012, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Concentration-Dependent Activity of Pazufloxacin against Pseudomonas aeruginosa: An In Vivo Pharmacokinetic/Pharmacodynamic Study

H. Terazono, K. Ikawa, N. Morikawa, 2022, Antibiotics.

Factors affecting treatment and recurrence of Clostridium difficile infections.

Kazuaki Matsumoto, K. Ikawa, N. Morikawa, 2014, Biological & pharmaceutical bulletin.

Gastrin-releasing peptide-like immunoreactive substance in bronchoalveolar lavage of idiopathic pulmonary fibrosis and sarcoidosis.

M. Kitaichi, T. Mio, S. Nagai, 1993, European Respiratory Journal.

Development and validation of a GC-EI-MS method with reduced adsorption loss for the quantification of olanzapine in human plasma

K. Ikawa, N. Morikawa, K. Ikeda, 2012, Analytical and Bioanalytical Chemistry.

Effect of Terfenadine on Substance P and Vasoactive Intestinal Polypeptide Concentrations in Nasal Secretions from Patients with Nasal Allergy

M. Takeyama, N. Morikawa, T. Chaen, 1994, The Journal of pharmacy and pharmacology.

Effect of terfenadine on the plasma concentrations of substance P and vasoactive intestinal polypeptide in volunteers

M. Takeyama, N. Morikawa, K. Mori, 1992, The Journal of pharmacy and pharmacology.

Population Pharmacokinetic–Pharmacodynamic Target Attainment Analysis of Imipenem Plasma and Urine Data in Neonates and Children

H. Ohge, K. Ikawa, N. Morikawa, 2013, The Pediatric infectious disease journal.

Optimisation of imipenem regimens in patients with impaired renal function by pharmacokinetic-pharmacodynamic target attainment analysis of plasma and urinary concentration data.

H. Kumon, H. Ohge, K. Ikawa, 2012, International journal of antimicrobial agents.

Gastrin releasing peptide-like immunoreactive substance in rat mammary glands during pregnancy.

A. Otaka, N. Fujii, M. Takeyama, 1991, Biochemical and biophysical research communications.

Pharmacokinetics of Etoposide in Plasma and Cerebrospinal Fluid in the Space Left by Tumor Removal

M. Takeyama, N. Morikawa, T. Mori, 1999, The Annals of pharmacotherapy.

Peritoneal Pharmacokinetics and Pharmacodynamic Target Attainment of Meropenem in Patients Undergoing Abdominal Surgery

H. Ohge, T. Sueda, K. Ikawa, 2010, Journal of chemotherapy.

Pharmacokinetics and Pharmacodynamic Assessment of Imipenem in the Intraperitoneal Fluid of Abdominal Surgery Patients

H. Ohge, T. Sueda, K. Ikawa, 2008, Chemotherapy.

Peritoneal pharmacokinetics of cefepime in laparotomy patients with inflammatory bowel disease, and dosage considerations for surgical intra-abdominal infections based on pharmacodynamic assessment

H. Houchi, H. Ohge, T. Sueda, 2008, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Estimation of the Supporting Functions for Prescription Making in an Order Entry System.

M. Takeyama, N. Morikawa, K. Higuchi, 1993 .

Development and Estimation of the Management System for Dispensing.

M. Takeyama, N. Morikawa, K. Higuchi, 1992 .

Prostatic Pharmacokinetic/Pharmacodynamic Evaluation of Ampicillin‐Sulbactam for Bacterial Prostatitis and Preoperative Prophylaxis

Kogenta Nakamura, K. Ikawa, N. Morikawa, 2020, Journal of clinical pharmacology.

Pharmacokinetic/pharmacodynamic analysis of teicoplanin in patients with MRSA infections

Kazuaki Matsumoto, K. Ikawa, N. Morikawa, 2016, Clinical pharmacology : advances and applications.

Pharmacokinetic-Pharmacodynamic Target Attainment Analysis of Biapenem in Adult Patients: A Dosing Strategy

H. Ohge, T. Sueda, K. Ikawa, 2008, Chemotherapy.

Population pharmacokinetics and pharmacodynamics of biapenem in paediatric patients

S. Nishimura, K. Ikawa, N. Morikawa, 2008, Journal of clinical pharmacy and therapeutics.

Safety analysis of liposomal amphotericin B in adult patients: anaemia, thrombocytopenia, nephrotoxicity, hepatotoxicity and hypokalaemia.

Kazuaki Matsumoto, K. Ikawa, N. Morikawa, 2011, International journal of antimicrobial agents.

Population pharmacokinetic-pharmacodynamic target attainment analysis of sulbactam in patients with impaired renal function: dosing considerations for Acinetobacter baumannii infections.

Kazuaki Matsumoto, K. Ikawa, N. Morikawa, 2015, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Pharmacokinetics and pharmacodynamics of once-daily arbekacin during continuous venovenous hemodiafiltration in critically ill patients

K. Ikawa, N. Morikawa, K. Ikeda, 2009, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Pharmacokinetics and pharmacodynamics of biapenem in critically ill patients under continuous venovenous hemodiafiltration.

K. Ikawa, N. Morikawa, K. Kaneko, 2008, The Japanese journal of antibiotics.

Pharmacokinetic modeling and dosage adaptation of biapenem in Japanese patients during continuous venovenous hemodiafiltration

K. Ikawa, N. Morikawa, K. Ikeda, 2008, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

The pharmacokinetics of low-dose thalidomide in Japanese patients with refractory multiple myeloma.

H. Asaoku, K. Ikawa, N. Morikawa, 2006, Biological & pharmaceutical bulletin.

Quantification of doripenem in human plasma and peritoneal fluid by high-performance liquid chromatography with ultraviolet detection.

H. Ohge, T. Sueda, K. Ikawa, 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Penetration of meropenem into human pancreatic juice

H. Ohge, Y. Murakami, T. Sueda, 2013, Scandinavian journal of infectious diseases.

Ceftolozane–Tazobactam Pharmacokinetics in the Abdominal Tissue of Patients Undergoing Lower Gastrointestinal Surgery: Dosing Considerations Based on Site-Specific Pharmacodynamic Target Attainment

Toshinori Hirano, N. Shigemoto, H. Ohge, 2022, Infectious Diseases and Therapy.

Population pharmacokinetics and pharmacodynamics of meropenem in Japanese pediatric patients

Masao Kobayashi, K. Ikawa, N. Morikawa, 2010, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Correlation between voriconazole trough plasma concentration and hepatotoxicity in patients with different CYP2C19 genotypes.

Kazuaki Matsumoto, K. Ikawa, N. Morikawa, 2009, International journal of antimicrobial agents.

Development of initial loading procedure for teicoplanin in critically ill patients with severe infections.

T. Yasuda, Kazuaki Matsumoto, Y. Kakihana, 2013, Biological and Pharmaceutical Bulletin.

Pharmacokinetics and dosing estimation of meropenem in Japanese patients receiving continuous venovenous hemodialysis.

Kazuaki Matsumoto, S. Hori, K. Ikawa, 2015, Journal of Infection and Chemotherapy.

Clinical pharmacokinetics of oral levofloxacin and sitafloxacin in epididymal tissue.

Masami Watanabe, Y. Ariyoshi, T. Sadahira, 2017, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

A simple and rapid determination of biapenem in plasma by high-performance liquid chromatography.

K. Ikawa, N. Morikawa, K. Ikeda, 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Determination of doripenem penetration into human prostate tissue and assessment of dosing regimens for prostatitis based on site-specific pharmacokinetic–pharmacodynamic evaluation

Kogenta Nakamura, K. Zennami, K. Ikawa, 2012, Journal of chemotherapy.

Penetration of doripenem into prostatic tissue following intravenous administration in prostatectomy patients.

Kogenta Nakamura, K. Ikawa, N. Morikawa, 2010, International journal of antimicrobial agents.

Peritoneal penetration of doripenem after intravenous administration in abdominal-surgery patients.

H. Ohge, T. Sueda, K. Ikawa, 2007, The Journal of antimicrobial chemotherapy.

Therapeutic drug monitoring of voriconazole in Japanese patients: analysis based on clinical practice data

Kazuaki Matsumoto, K. Ikawa, N. Morikawa, 2016, Journal of chemotherapy.

Clinical pharmacokinetics and pharmacodynamic target attainment of pazufloxacin in prostate tissue: Dosing considerations for prostatitis.

Kogenta Nakamura, M. Sumitomo, K. Zennami, 2017, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Pharmacokinetics and pharmacodynamic target attainment of intravenous pazufloxacin in the bile of patients undergoing biliary pancreatic surgery

N. Shigemoto, H. Ohge, Y. Murakami, 2014, Journal of chemotherapy.

Pharmacokinetic/pharmacodynamic evaluation of sulbactam against Acinetobacter baumannii in in vitro and murine thigh and lung infection models.

Kazuaki Matsumoto, K. Ikawa, N. Morikawa, 2014, International journal of antimicrobial agents.

Clinical pharmacokinetics of flomoxef in prostate tissue and dosing considerations for prostatitis based on site-specific pharmacodynamic target attainment.

Kogenta Nakamura, K. Ikawa, N. Morikawa, 2019, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Penetration of piperacillin-tazobactam into human prostate tissue and dosing considerations for prostatitis based on site-specific pharmacokinetics and pharmacodynamics.

Kogenta Nakamura, M. Sumitomo, K. Zennami, 2015, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Prostatic penetration of meropenem in humans, and dosage considerations for prostatitis based on a site-specific pharmacokinetic/pharmacodynamic evaluation.

Kogenta Nakamura, M. Sumitomo, K. Zennami, 2013, International journal of antimicrobial agents.

Clinical Pharmacokinetics of Meropenem and Biapenem in Bile and Dosing Considerations for Biliary Tract Infections Based on Site-Specific Pharmacodynamic Target Attainment

H. Derendorf, H. Ohge, Y. Murakami, 2011, Antimicrobial Agents and Chemotherapy.

Pharmacokinetic-pharmacodynamic target attainment analysis of cefozopran in Japanese adult patients

M. Taniwaki, H. Ohge, T. Sueda, 2008, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Lafutidine, a Newly Developed Antiulcer Drug, Elevates Postprandial Intragastric pH and Increases Plasma Calcitonin Gene-Related Peptide and Somatostatin Concentrations in Humans: Comparisons with Famotidine

J. Xu, S. Tazuma, K. Ikawa, 2006, Digestive Diseases and Sciences.

Pharmacokinetics of Anticancer Drugs in Cerebrospinal Fluid

M. Takeyama, N. Morikawa, S. Hori, 1998, The Annals of pharmacotherapy.

Calcitonin gene‐related peptide and somatostatin releases correlated with the area under the lafutidine concentration–time curve in human plasma

K. Ikawa, N. Morikawa, T. Shimatani, 2006, Journal of clinical pharmacy and therapeutics.

Pharmacokinetics of nimustine, cytosine arabinoside, and methotrexate in cerebrospinal fluid during cerebrospinal fluid perfusion chemotherapy.

T. Abe, M. Takeyama, N. Morikawa, 2001, Biological & pharmaceutical bulletin.

Pharmacokinetics of nimustine, methotrexate, and cytosine arabinoside during cerebrospinal fluid perfusion chemotherapy in patients with disseminated brain tumors

M. Fujiki, T. Abe, M. Takeyama, 1998, European Journal of Clinical Pharmacology.

The Pharmacokinetics and Pharmacodynamics of Meropenem in the Cerebrospinal Fluid of Neurosurgical Patients

K. Kurisu, K. Iida, K. Ikawa, 2008, Journal of chemotherapy.

Pharmacokinetic/pharmacodynamic evaluation of teicoplanin against Staphylococcus aureus in murine thigh infection model.

Kazuaki Matsumoto, H. Terazono, K. Ikawa, 2017, Journal of global antimicrobial resistance.

An initial dosing method for teicoplanin based on the area under the serum concentration time curve required for MRSA eradication

Kazuaki Matsumoto, K. Ikawa, N. Morikawa, 2011, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

LC Determination of Total Cefotiam Concentration in Human Serum: Application of Ultrafiltration to a High Protein-Binding Drug

T. Tsukamoto, K. Ikawa, N. Morikawa, 2010 .

Pharmacokinetics of cefmetazole in plasma, peritoneal fluid, peritoneum, and subcutaneous adipose tissue of patients scheduled for lower gastrointestinal surgery: Dosing considerations based on site-specific pharmacodynamic target attainment.

Toshinori Hirano, N. Shigemoto, K. Ikawa, 2022, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Nephrotoxicity induced by piperacillin–tazobactam in late elderly Japanese patients with nursing and healthcare associated pneumonia.

K. Ikawa, N. Morikawa, N. Ishihara, 2014, Biological & pharmaceutical bulletin.

Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction.

Kazuaki Matsumoto, K. Ikawa, N. Morikawa, 2010, International journal of antimicrobial agents.

Analysis of thrombocytopenic effects and population pharmacokinetics of linezolid: a dosage strategy according to the trough concentration target and renal function in adult patients.

Kazuaki Matsumoto, K. Ikawa, N. Morikawa, 2014, International journal of antimicrobial agents.

Determination of teicoplanin trough concentration target and appropriate total dose during the first 3 days: a retrospective study in patients with MRSA infections

Kazuaki Matsumoto, K. Ikawa, N. Morikawa, 2010, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Pharmacokinetic and pharmacodynamic simulation for the quantitative risk assessment of linezolid‐associated thrombocytopenia

K. Ikawa, N. Morikawa, N. Ishihara, 2022, Journal of clinical pharmacy and therapeutics.

Population pharmacokinetics/pharmacodynamics of linezolid in sepsis patients with and without continuous renal replacement therapy.

S. Nishi, K. Ikawa, N. Morikawa, 2018, International journal of antimicrobial agents.

Linezolid dosage in pediatric patients based on pharmacokinetics and pharmacodynamics.

Kazuaki Matsumoto, K. Ikawa, N. Morikawa, 2015, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Renal function as a predictor of linezolid-induced thrombocytopenia.

Kazuaki Matsumoto, K. Ikawa, N. Morikawa, 2009, International journal of antimicrobial agents.

Pharmacokinetics of ampicillin–sulbactam and the renal function-based optimization of dosing regimens for prophylaxis in patients undergoing cardiovascular surgery

Kazuaki Matsumoto, K. Ikawa, N. Morikawa, 2012, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Clinical pharmacokinetics of meropenem in pancreatic juice and site-specific pharmacodynamic target attainment against Gram-negative bacteria: dosing considerations.

H. Ohge, Y. Murakami, K. Uemura, 2014, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

The pharmacokinetics of oral metronidazole in patients with metronidazole‐induced encephalopathy undergoing maintenance hemodialysis

T. Kuragano, Mana Yahiro, K. Ikawa, 2020, Hemodialysis international. International Symposium on Home Hemodialysis.

Pharmacokinetics of Oral and Intravenous Melphalan in Japanese Patients with Multiple Myeloma

H. Asaoku, K. Ikawa, N. Morikawa, 2007 .

Pharmacokinetics of Prophylactic Ampicillin-Sulbactam and Dosing Optimization in Patients Undergoing Cardiovascular Surgery with Cardiopulmonary Bypass.

Kazuaki Matsumoto, K. Ikawa, N. Morikawa, 2015, Biological & pharmaceutical bulletin.

High-performance liquid chromatography with ultraviolet detection for real-time therapeutic drug monitoring of meropenem in plasma.

Masao Kobayashi, K. Ikawa, N. Morikawa, 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Pharmacokinetics of flomoxef in plasma, peritoneal fluid, peritoneum, and subcutaneous adipose tissue of patients undergoing lower gastrointestinal surgery: Dosing considerations based on site-specific pharmacodynamic target attainment.

Toshinori Hirano, N. Shigemoto, K. Ikawa, 2022, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Assessment of micafungin regimens by pharmacokinetic-pharmacodynamic analysis: a dosing strategy for Aspergillus infections.

M. Taniwaki, K. Ikawa, N. Morikawa, 2009, The Journal of antimicrobial chemotherapy.

Pharmacokinetics and outcome of tazobactam/piperacillin in Japanese patients undergoing low-flow continuous renal replacement therapy: dosage considerations

S. Nishi, K. Ikawa, N. Morikawa, 2017, Clinical pharmacology : advances and applications.

Pharmacokinetic Study in Acute Antiepileptic Intoxication Treated with Hemodialysis and Hemoperfusion.

M. Takeyama, N. Morikawa, K. Mori, 1992 .

Prostatic Penetration of Meropenem after Intravenous Administration in Patients Undergoing Transurethral Resection of the Prostate

K. Ikawa, N. Morikawa, N. Honda, 2011, Journal of chemotherapy.

Penetrability of Intravenous Biapenem Into the Peritoneal Fluid of Laparotomy Patients and the Peritoneal Pharmacodynamics Against Gram-negative Bacteria

H. Ohge, T. Sueda, K. Ikawa, 2009 .

Longitudinal Pharmacokinetic Study of β-carotene

H. Terada, M. Takeyama, N. Morikawa, 1989 .

Clinical pharmacokinetics of oral azithromycin in epididymal tissue.

Masami Watanabe, T. Sadahira, M. Araki, 2019, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Pharmacokinetics and skin-tissue penetration of daptomycin in rats

Kazuaki Matsumoto, S. Hori, J. Sasaki, 2015, Clinical pharmacology : advances and applications.

Pharmacokinetic–pharmacodynamic target attainment analysis of meropenem in Japanese adult patients

K. Kurisu, M. Taniwaki, H. Ohge, 2010, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Pharmacokinetic-pharmacodynamic target attainment analysis of doripenem in infected patients.

H. Kumon, K. Ikawa, N. Morikawa, 2009, International journal of antimicrobial agents.

Enzyme immunoassay of angiotensin II in human plasma.

M. Takeyama, N. Morikawa, A. Kawano, 1992, Chemical & pharmaceutical bulletin.

Pharmacodynamic Evaluation of Ampicillin-sulbactam in Pediatric Patients Using Plasma and Urine Data

K. Ikawa, N. Morikawa, N. Ishihara, 2022, The Pediatric Infectious Disease Journal.

Development and Evaluation of Software to Simulate Clinical Training in Primary Care for Outpatients at Department of Pharmacotherapy, Hiroshima University Hopsital

S. Tazuma, M. Yokozaki, K. Ikawa, 2006 .

Development of breakpoints of cephems for intraabdominal infections based on pharmacokinetics and pharmacodynamics in the peritoneal fluid of patients

H. Ohge, T. Sueda, K. Ikawa, 2008, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

The pharmacokinetics of ampicillin–sulbactam in anuric patients: dosing optimization for prophylaxis during cardiovascular surgery

Kazuaki Matsumoto, K. Ikawa, N. Morikawa, 2016, International Journal of Clinical Pharmacy.

Population pharmacokinetic modeling and pharmacodynamic assessment of cefozopran in pediatric patients.

K. Ikawa, N. Morikawa, R. Kobayashi, 2009, The Japanese journal of antibiotics.

Pulmonary Pharmacokinetic and Pharmacodynamic Evaluation of Ampicillin/Sulbactam Regimens for Pneumonia Caused by Various Bacteria, including Acinetobacter baumannii

K. Ikawa, N. Morikawa, N. Ishihara, 2023, Antibiotics.

Pharmacodynamic evaluation of biapenem in peritoneal fluid using population pharmacokinetic modelling and Monte Carlo simulation.

H. Ohge, T. Sueda, K. Ikawa, 2008, International journal of antimicrobial agents.

Penetration and Exposure of Cefotiam into the Peritoneal Fluid of Abdominal Surgery Patients after Intravenous Administration

H. Ohge, T. Sueda, K. Ikawa, 2008, Journal of chemotherapy.

Peritoneal penetration and pharmacodynamic exposure of intravenous cefozopran in abdominal surgery patients.

H. Ohge, T. Sueda, K. Ikawa, 2007, International journal of antimicrobial agents.

Penetration into and exposure of cefozopran in pelvic retroperitoneal space exudate

K. Ikawa, N. Morikawa, T. Tamaya, 2008, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Development of breakpoints of carbapenems for intraabdominal infections based on pharmacokinetics and pharmacodynamics in peritoneal fluid

H. Ohge, T. Sueda, K. Ikawa, 2008, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Progressive Trial on Clinical Pharmacy Services in a Hospital (II). Therapeutic Drug Monitoring of Methotrexate during the High Dose Methotrexate Therpy.

M. Takeyama, N. Morikawa, K. Kumagai, 1994 .

Methotrexate concentration in cerebrospinal fluid of the space created by tumor removal.

M. Takeyama, N. Morikawa, T. Mori, 2000, Biological & pharmaceutical bulletin.

M. Takeyama, N. Morikawa, S. Hori, 1999, The Annals of pharmacotherapy.

PHARMACOKINETICS OFMETHOTREXATE INPLASMA AND CEREBROSPINAL FLUID

T. Abe, M. Takeyama, N. Morikawa, 1997 .

Plasma Concentrations of Clonazepam Therapy in Epileptic Children

M. Takeyama, K. Ikawa, N. Morikawa, 1997 .

Pharmacokinetics of etoposide and carboplatin in cerebrospinal fluid and plasma during hyperosmotic disruption of the blood brain barrier and intraarterial combination chemotherapy.

M. Takeyama, N. Morikawa, Teruaki Mori, 1999, Biological & pharmaceutical bulletin.

Pharmacokinetics and skin-tissue penetration of daptomycin in rats

Kazuaki Matsumoto, K. Ikawa, N. Morikawa, 2015 .

Pharmacokinetic/pharmacodynamic evaluation of sulbactam against Acinetobacter baumannii in in vitro and murine thigh and lung infection models.

Kazuaki Matsumoto, K. Ikawa, N. Morikawa, 2014, International journal of antimicrobial agents.

Pharmacokinetics of propofol in elderly coronary artery bypass graft patients under total intravenous anesthesia.

M. Takeyama, N. Morikawa, T. Noguchi, 2002, Biological & pharmaceutical bulletin.

Is Extended Administration Time and/or Frequent Administration of Biapnem Always Effective?

K. Ikawa, N. Morikawa, K. Ikeda, 2008 .

Clinical Pharmacology: Advances and Applications Dovepress Pharmacokinetic/pharmacodynamic Analysis of Teicoplanin in Patients with Mrsa Infections

Kazuaki Matsumoto, K. Ikawa, N. Morikawa, 2022 .